Staging and grading of ovarian cancer
The stage and grade of ovarian cancer, fallopian tube cancer and primary peritoneal cancer describes its size, whether it has spread and how quickly it may grow.
Staging cancer of the ovary, fallopian tube or peritoneum
The stage of a cancer describes its size and whether it has spread from where it started. Knowing the stage helps your doctors and nurses plan the best treatment for you.
If you are having surgery, your doctor will usually not know the exact stage until the cancer has been removed.
If you are not having surgery, doctors use tests and CT scan, to decide the stage of the cancer.
Doctors use FIGO staging for cancer of the ovary, fallopian tube cancer and primary peritoneal cancer. This system uses numbers and letters to describe the stages.
Side view ovarian with ureter
Lymph nodes in the abdomen and pelvis
Stage 1
This is described as early cancer.
Stage 1a
The cancer is only within 1 ovary or 1 fallopian tube and does not affect the surface.
Stage 1b
The cancer is in both ovaries or both fallopian tubes.
Stage 1c
The cancer is in 1 or both ovaries or fallopian tubes, and 1 or more of the following has happened:
- The surface (capsule) of the ovary or fallopian tube has broken. This may have caused cancer cells to leak into the tummy (abdomen) or pelvis (the lower area between the hips).
- Cancer cells are on the surface of the ovaries or fallopian tubes.
- Cancer cells are in the fluid in the tummy or pelvis.
Stage 2
The cancer is in 1 or both ovaries or fallopian tubes and has grown into nearby areas inside the pelvis.
Or the cancer has started in the peritoneum but only affects areas inside the pelvis. The peritoneum is the layer of tissue that covers the ovaries and fallopian tubes.
Stage 2a
Cancer is in the womb, fallopian tubes or ovaries.
Stage 2b
Cancer is in other structures in the pelvis, such as the bowel or bladder.
Stage 3
Cancer is in 1 or both ovaries or fallopian tubes or in the peritoneum. It has also spread to:
- the lymph nodes in the pelvis or tummy (the retroperitoneal nodes)
- parts of the peritoneum outside the pelvis.
Stage 3a1
The cancer has spread to the retroperitoneal nodes. This stage is further divided depending on whether the cancer is bigger or smaller than 1cm in diameter.
Stage 3a2
Very small amounts of cancer have spread to parts of the peritoneum outside the pelvis. Cancer may also be in the retroperitoneal nodes.
Stage 3b
The cancer is in parts of the peritoneum outside the pelvis. These areas are up to 2cm in diameter. Cancer may also be in the retroperitoneal nodes.
Stage 3c
Cancer is in parts of the peritoneum outside the pelvis. These areas are larger than 2cm in diameter. Cancer may also be in the retroperitoneal nodes. It may have spread to the capsule that surrounds the liver and spleen, but not inside these organs.
Stage 4
The cancer has spread to other parts of the body outside the tummy.
Stage 4a
The cancer has caused a build-up of fluid in the lining of the lungs (the pleura). This is called a pleural effusion.
Stage 4b
The cancer has spread to the inside of the liver or spleen. Or the cancer has spread to lymph nodes or organs outside the tummy, such as the lungs or armpits.
Further resources
The charity Target Ovarian Cancer have a which gives more information about the different stages and substages of ovarian cancer. It shows staging for cancers that start in the ovaries and fallopian tubes but not in the peritoneum.
Grading cancer of the ovary, fallopian tube or peritoneum
Grading describes how the cancer cells look under the microscope compared with normal cells. Knowing the grade helps your doctors plan your treatment.
Cancer of the ovary, fallopian tube or peritoneum is graded as:
- Low grade or well differentiated (grade 1) – the cancer cells look very like normal cells. They usually grow slowly and are less likely to spread.
- Moderate or intermediate grade (grade 2) – the cancer cells look more abnormal. They are slightly faster growing.
- High grade or poorly differentiated (grade 3) – the cancer cells look very different from normal cells. They usually grow more quickly.
Most epithelial ovarian cancers are high grade serous cancers.
Doctors do not grade borderline tumours. This is because borderline tumours are made up of abnormal cells rather than cancer cells.
About our information
This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer.
-
References
Below is a sample of the sources used in our ovarian cancer information. If you would like more information about the sources we use, please contact us at informationproductionteam@macmillan.org.uk
Ovarian cancer: recognition and initial management. Clinical guideline [CG122] Published: 27 April 2011 Last updated: 02 October 2023 www.nice.org.uk/guidance/cg122 (accessed May 2024)
Ovarian cancer: identifying and managing familial and genetic risk. NICE guideline [NG241]. Published: 21 March 2024 www.nice.org.uk/guidance/ng241 (accessed May 2024)
A. González-Martín, P. Harter, A. Leary, D. Lorusso, R. E. Miller, B. Pothuri, I. Ray-Coquard, D. S. P. Tan, E. Bellet, A. Oaknin & J. A. Ledermann, on behalf of the ESMO Guidelines Committee. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Published August 17, 2023. www.annalsofoncology.org/article/S0923-7534(23)00797-4/fulltext (accessed May 2024)
Date reviewed

Our cancer information meets the PIF TICK quality mark.
This means it is easy to use, up-to-date and based on the latest evidence. Learn more about how we produce our information.
The language we use
We want everyone affected by cancer to feel our information is written for them.
We want our information to be as clear as possible. To do this, we try to:
- use plain English
- explain medical words
- use short sentences
- use illustrations to explain text
- structure the information clearly
- make sure important points are clear.
We use gender-inclusive language and talk to our readers as ‘you’ so that everyone feels included. Where clinically necessary we use the terms ‘men’ and ‘women’ or ‘male’ and ‘female’. For example, we do so when talking about parts of the body or mentioning statistics or research about who is affected.
You can read more about how we produce our information here.
